

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 6.41012139 |
| 2 | presynaptic membrane assembly (GO:0097105) | 5.10199087 |
| 3 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.99039162 |
| 4 | postsynaptic membrane organization (GO:0001941) | 4.87885553 |
| 5 | thrombin receptor signaling pathway (GO:0070493) | 4.67309706 |
| 6 | positive regulation of mast cell activation (GO:0033005) | 4.53052258 |
| 7 | presynaptic membrane organization (GO:0097090) | 4.51718816 |
| 8 | neutrophil activation (GO:0042119) | 4.50241718 |
| 9 | neuron cell-cell adhesion (GO:0007158) | 4.38945105 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.20167179 |
| 11 | regulation of platelet aggregation (GO:0090330) | 4.00172532 |
| 12 | granulocyte activation (GO:0036230) | 3.95174772 |
| 13 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.92333801 |
| 14 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.88236817 |
| 15 | neuronal action potential propagation (GO:0019227) | 3.86279537 |
| 16 | regulation of platelet activation (GO:0010543) | 3.83319992 |
| 17 | protein neddylation (GO:0045116) | 3.81355512 |
| 18 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.73737844 |
| 19 | regulation of mast cell activation (GO:0033003) | 3.71763374 |
| 20 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.69168383 |
| 21 | positive regulation of mast cell degranulation (GO:0043306) | 3.60293809 |
| 22 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.60293809 |
| 23 | respiratory chain complex IV assembly (GO:0008535) | 3.59408363 |
| 24 | regulation of mast cell degranulation (GO:0043304) | 3.56154064 |
| 25 | vocalization behavior (GO:0071625) | 3.54094273 |
| 26 | negative regulation of cell killing (GO:0031342) | 3.52822664 |
| 27 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.52822664 |
| 28 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.48109969 |
| 29 | leukocyte degranulation (GO:0043299) | 3.47112828 |
| 30 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.44753626 |
| 31 | cytochrome complex assembly (GO:0017004) | 3.40985340 |
| 32 | microglial cell activation (GO:0001774) | 3.37646782 |
| 33 | protein complex biogenesis (GO:0070271) | 3.37240451 |
| 34 | lipoxygenase pathway (GO:0019372) | 3.35840194 |
| 35 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.33127809 |
| 36 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.29919071 |
| 37 | protein localization to cilium (GO:0061512) | 3.29872165 |
| 38 | positive regulation of B cell differentiation (GO:0045579) | 3.26140537 |
| 39 | protein localization to synapse (GO:0035418) | 3.25528633 |
| 40 | righting reflex (GO:0060013) | 3.24248424 |
| 41 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.24040576 |
| 42 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.21123869 |
| 43 | immunoglobulin mediated immune response (GO:0016064) | 3.20435039 |
| 44 | cellular extravasation (GO:0045123) | 3.19001264 |
| 45 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.17816802 |
| 46 | myeloid cell activation involved in immune response (GO:0002275) | 3.17573134 |
| 47 | startle response (GO:0001964) | 3.14855363 |
| 48 | detection of other organism (GO:0098543) | 3.11714439 |
| 49 | detection of bacterium (GO:0016045) | 3.10838208 |
| 50 | positive regulation of synapse assembly (GO:0051965) | 3.10834964 |
| 51 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.10374658 |
| 52 | dopamine transport (GO:0015872) | 3.09071849 |
| 53 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.08649843 |
| 54 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.08244148 |
| 55 | superoxide anion generation (GO:0042554) | 3.04778427 |
| 56 | positive regulation by symbiont of host defense response (GO:0052509) | 3.04136367 |
| 57 | modulation by symbiont of host defense response (GO:0052031) | 3.04136367 |
| 58 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.04136367 |
| 59 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.04136367 |
| 60 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.04136367 |
| 61 | modulation by symbiont of host immune response (GO:0052553) | 3.04136367 |
| 62 | purinergic receptor signaling pathway (GO:0035587) | 3.04069483 |
| 63 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.04021688 |
| 64 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.04021688 |
| 65 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.02976765 |
| 66 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.01277923 |
| 67 | response to peptidoglycan (GO:0032494) | 3.00739498 |
| 68 | glutamate receptor signaling pathway (GO:0007215) | 3.00673814 |
| 69 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.98940875 |
| 70 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.97864816 |
| 71 | neuron-neuron synaptic transmission (GO:0007270) | 2.97699644 |
| 72 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.97656941 |
| 73 | DNA deamination (GO:0045006) | 2.97223418 |
| 74 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.96847643 |
| 75 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.96633761 |
| 76 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.95503020 |
| 77 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.95503020 |
| 78 | NADH dehydrogenase complex assembly (GO:0010257) | 2.95503020 |
| 79 | mannosylation (GO:0097502) | 2.90550655 |
| 80 | short-term memory (GO:0007614) | 2.90018827 |
| 81 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.89090353 |
| 82 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.88564297 |
| 83 | developmental pigmentation (GO:0048066) | 2.87263877 |
| 84 | regulation of gamma-delta T cell activation (GO:0046643) | 2.86807246 |
| 85 | negative regulation of heart rate (GO:0010459) | 2.86424049 |
| 86 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.83560341 |
| 87 | synaptic transmission, glutamatergic (GO:0035249) | 2.82807313 |
| 88 | mast cell activation (GO:0045576) | 2.80644002 |
| 89 | synaptic transmission, dopaminergic (GO:0001963) | 2.79484210 |
| 90 | respiratory electron transport chain (GO:0022904) | 2.78787397 |
| 91 | adenosine receptor signaling pathway (GO:0001973) | 2.78426863 |
| 92 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.74175716 |
| 93 | electron transport chain (GO:0022900) | 2.72865398 |
| 94 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.72100885 |
| 95 | regulation of regulatory T cell differentiation (GO:0045589) | 2.71726889 |
| 96 | GTP biosynthetic process (GO:0006183) | 2.71439148 |
| 97 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.70804767 |
| 98 | regulation of pigment cell differentiation (GO:0050932) | 2.70611720 |
| 99 | response to histamine (GO:0034776) | 2.70399621 |
| 100 | megakaryocyte development (GO:0035855) | 2.70011706 |
| 101 | B cell mediated immunity (GO:0019724) | 2.68806178 |
| 102 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.67942002 |
| 103 | serotonin receptor signaling pathway (GO:0007210) | 2.66805896 |
| 104 | regulation of thymocyte apoptotic process (GO:0070243) | 2.66499742 |
| 105 | regulation of leukocyte degranulation (GO:0043300) | 2.66115173 |
| 106 | autophagic vacuole fusion (GO:0000046) | 2.65945990 |
| 107 | angiogenesis involved in wound healing (GO:0060055) | 2.65415585 |
| 108 | positive regulation of neurotransmitter transport (GO:0051590) | 2.65188570 |
| 109 | regulation of memory T cell differentiation (GO:0043380) | 2.64060743 |
| 110 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.63571742 |
| 111 | positive regulation of granulocyte differentiation (GO:0030854) | 2.62958341 |
| 112 | negative regulation of interleukin-12 production (GO:0032695) | 2.62915217 |
| 113 | B cell receptor signaling pathway (GO:0050853) | 2.62829817 |
| 114 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.61051017 |
| 115 | regulation of timing of cell differentiation (GO:0048505) | 2.60679868 |
| 116 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.60441224 |
| 117 | cellular biogenic amine catabolic process (GO:0042402) | 2.60299358 |
| 118 | amine catabolic process (GO:0009310) | 2.60299358 |
| 119 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.60166842 |
| 120 | neurotransmitter uptake (GO:0001504) | 2.59774417 |
| 121 | regulation of respiratory system process (GO:0044065) | 2.59074772 |
| 122 | activated T cell proliferation (GO:0050798) | 2.58855103 |
| 123 | synaptic vesicle exocytosis (GO:0016079) | 2.58181802 |
| 124 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.57357605 |
| 125 | chaperone-mediated protein transport (GO:0072321) | 2.57309289 |
| 126 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.57145088 |
| 127 | regulation of B cell differentiation (GO:0045577) | 2.57130378 |
| 128 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.56492596 |
| 129 | transmission of nerve impulse (GO:0019226) | 2.56421267 |
| 130 | negative regulation of T cell apoptotic process (GO:0070233) | 2.55956874 |
| 131 | axon ensheathment in central nervous system (GO:0032291) | 2.55938278 |
| 132 | central nervous system myelination (GO:0022010) | 2.55938278 |
| 133 | response to host immune response (GO:0052572) | 2.55762670 |
| 134 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.55762670 |
| 135 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.55022096 |
| 136 | platelet aggregation (GO:0070527) | 2.54898948 |
| 137 | actin nucleation (GO:0045010) | 2.54689661 |
| 138 | positive regulation of membrane potential (GO:0045838) | 2.54090553 |
| 139 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.53797657 |
| 140 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.53570541 |
| 141 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.53570541 |
| 142 | positive regulation of amino acid transport (GO:0051957) | 2.52554819 |
| 143 | negative regulation of neurotransmitter transport (GO:0051589) | 2.52271627 |
| 144 | regulation of protein kinase A signaling (GO:0010738) | 2.51956981 |
| 145 | macrophage activation involved in immune response (GO:0002281) | 2.51656195 |
| 146 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.50556403 |
| 147 | leukocyte aggregation (GO:0070486) | 2.50537884 |
| 148 | detection of external biotic stimulus (GO:0098581) | 2.49943858 |
| 149 | mast cell activation involved in immune response (GO:0002279) | 2.48847017 |
| 150 | mast cell degranulation (GO:0043303) | 2.48847017 |
| 151 | regulation of glutamate secretion (GO:0014048) | 2.48260793 |
| 152 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.47776497 |
| 153 | macrophage activation (GO:0042116) | 2.47037026 |
| 154 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.47036111 |
| 155 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.46541358 |
| 156 | ATP synthesis coupled proton transport (GO:0015986) | 2.46541358 |
| 157 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.46163383 |
| 158 | monoamine transport (GO:0015844) | 2.45763187 |
| 159 | positive regulation of action potential (GO:0045760) | 2.45484459 |
| 160 | long-term memory (GO:0007616) | 2.45479862 |
| 161 | negative regulation of platelet activation (GO:0010544) | 2.44240346 |
| 162 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.44202541 |
| 163 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.44202541 |
| 164 | blood coagulation, intrinsic pathway (GO:0007597) | 2.44175280 |
| 165 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.44064408 |
| 166 | GPI anchor biosynthetic process (GO:0006506) | 2.42775821 |
| 167 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.42573176 |
| 168 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.42515836 |
| 169 | cardiolipin metabolic process (GO:0032048) | 2.41980776 |
| 170 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.41539081 |
| 171 | regulation of synapse assembly (GO:0051963) | 2.41441055 |
| 172 | negative regulation of response to food (GO:0032096) | 2.41018820 |
| 173 | negative regulation of appetite (GO:0032099) | 2.41018820 |
| 174 | regulation of regulated secretory pathway (GO:1903305) | 2.40848879 |
| 175 | adult walking behavior (GO:0007628) | 2.40776086 |
| 176 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.40586253 |
| 177 | cranial nerve structural organization (GO:0021604) | 2.40022594 |
| 178 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.39538358 |
| 179 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.39538358 |
| 180 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.38877369 |
| 181 | photoreceptor cell maintenance (GO:0045494) | 2.38120472 |
| 182 | nonmotile primary cilium assembly (GO:0035058) | 2.37849426 |
| 183 | positive regulation of type 2 immune response (GO:0002830) | 2.37653172 |
| 184 | facial nerve structural organization (GO:0021612) | 2.35088368 |
| 185 | mechanosensory behavior (GO:0007638) | 2.33972845 |
| 186 | regulation of respiratory gaseous exchange (GO:0043576) | 2.33796086 |
| 187 | keratinocyte development (GO:0003334) | 2.32735961 |
| 188 | cAMP catabolic process (GO:0006198) | 2.31057318 |
| 189 | sympathetic nervous system development (GO:0048485) | 2.29675013 |
| 190 | opioid receptor signaling pathway (GO:0038003) | 2.29299643 |
| 191 | protein heterotetramerization (GO:0051290) | 2.28691000 |
| 192 | regulation of development, heterochronic (GO:0040034) | 2.28614651 |
| 193 | cyclic nucleotide catabolic process (GO:0009214) | 2.28260771 |
| 194 | synapse assembly (GO:0007416) | 2.28232361 |
| 195 | regulation of catecholamine metabolic process (GO:0042069) | 2.27871594 |
| 196 | regulation of dopamine metabolic process (GO:0042053) | 2.27871594 |
| 197 | rhodopsin mediated signaling pathway (GO:0016056) | 2.27495427 |
| 198 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.27290682 |
| 199 | intraciliary transport (GO:0042073) | 2.27220744 |
| 200 | cilium movement (GO:0003341) | 2.27144654 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.96651289 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.03859094 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.74712795 |
| 4 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.42632774 |
| 5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.30866175 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.09775083 |
| 7 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.96423415 |
| 8 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.94322357 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.91597401 |
| 10 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.85562999 |
| 11 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.84204461 |
| 12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.78333589 |
| 13 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.65560684 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.51097839 |
| 15 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.48712186 |
| 16 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.45896482 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.40600623 |
| 18 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.36876950 |
| 19 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.36225591 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.29550517 |
| 21 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.21072393 |
| 22 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.20749482 |
| 23 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.20368249 |
| 24 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.13957909 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.13878889 |
| 26 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.11983619 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.11912588 |
| 28 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.11272676 |
| 29 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.10536790 |
| 30 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 2.07476967 |
| 31 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.07239708 |
| 32 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.05303548 |
| 33 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.03020375 |
| 34 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98754652 |
| 35 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.96032141 |
| 36 | SPI1_23127762_ChIP-Seq_K562_Human | 1.95946461 |
| 37 | GATA1_19941826_ChIP-Seq_K562_Human | 1.92113424 |
| 38 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.91176276 |
| 39 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.91176276 |
| 40 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.89047408 |
| 41 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.87536295 |
| 42 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.86390060 |
| 43 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.83193895 |
| 44 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.81856034 |
| 45 | VDR_22108803_ChIP-Seq_LS180_Human | 1.81699658 |
| 46 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.76029503 |
| 47 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.75371542 |
| 48 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.74585116 |
| 49 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.73739145 |
| 50 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.71961383 |
| 51 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.71843192 |
| 52 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.71296481 |
| 53 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.70956912 |
| 54 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.70708089 |
| 55 | P300_19829295_ChIP-Seq_ESCs_Human | 1.69687734 |
| 56 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.66192025 |
| 57 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.62874271 |
| 58 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.61667267 |
| 59 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.61592274 |
| 60 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.61192212 |
| 61 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.59753942 |
| 62 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.59262011 |
| 63 | FUS_26573619_Chip-Seq_HEK293_Human | 1.58866513 |
| 64 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.58742605 |
| 65 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.57611889 |
| 66 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.57460980 |
| 67 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.56351207 |
| 68 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.55468075 |
| 69 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.54260857 |
| 70 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.52436175 |
| 71 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.49570996 |
| 72 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.48695234 |
| 73 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.48410433 |
| 74 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.48231974 |
| 75 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.47458869 |
| 76 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.47325991 |
| 77 | GATA2_19941826_ChIP-Seq_K562_Human | 1.46768060 |
| 78 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.44459200 |
| 79 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.44393961 |
| 80 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.44327265 |
| 81 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.44157022 |
| 82 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.41917381 |
| 83 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.40942911 |
| 84 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40741683 |
| 85 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.40597499 |
| 86 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.40252576 |
| 87 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.40125571 |
| 88 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.40121880 |
| 89 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.37859917 |
| 90 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.37147129 |
| 91 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.36830702 |
| 92 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.36678819 |
| 93 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.35136877 |
| 94 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.34850718 |
| 95 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.34646783 |
| 96 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.32927446 |
| 97 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.31765770 |
| 98 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.31451592 |
| 99 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.31146848 |
| 100 | GATA3_26560356_Chip-Seq_TH2_Human | 1.30512254 |
| 101 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29334871 |
| 102 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.28990377 |
| 103 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.28404733 |
| 104 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.28010808 |
| 105 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.27653717 |
| 106 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.26522660 |
| 107 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.24094891 |
| 108 | UTX_26944678_Chip-Seq_JUKART_Human | 1.23782116 |
| 109 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.22820459 |
| 110 | EWS_26573619_Chip-Seq_HEK293_Human | 1.22722515 |
| 111 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.22489965 |
| 112 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.21493240 |
| 113 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.21384143 |
| 114 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.21235003 |
| 115 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.19633529 |
| 116 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19464164 |
| 117 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.18346550 |
| 118 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.18223208 |
| 119 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.18215199 |
| 120 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.18195054 |
| 121 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18055104 |
| 122 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.18012841 |
| 123 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.17931089 |
| 124 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.17465777 |
| 125 | MYB_26560356_Chip-Seq_TH2_Human | 1.17344602 |
| 126 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.17180761 |
| 127 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.17072339 |
| 128 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.16955384 |
| 129 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.16427424 |
| 130 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.13947420 |
| 131 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.12973942 |
| 132 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12116458 |
| 133 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.11653139 |
| 134 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.10316217 |
| 135 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.09602548 |
| 136 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.08319254 |
| 137 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.07819895 |
| 138 | P300_27268052_Chip-Seq_Bcells_Human | 1.07816103 |
| 139 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07470867 |
| 140 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07281514 |
| 141 | KDM2B_26808549_Chip-Seq_REH_Human | 1.07183069 |
| 142 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.06767056 |
| 143 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.06743846 |
| 144 | AR_25329375_ChIP-Seq_VCAP_Human | 1.06581143 |
| 145 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.05807065 |
| 146 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05709391 |
| 147 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05414857 |
| 148 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.05382788 |
| 149 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04540923 |
| 150 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.04423365 |
| 151 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.04068276 |
| 152 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.03797192 |
| 153 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.03116499 |
| 154 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.02818776 |
| 155 | MAF_26560356_Chip-Seq_TH1_Human | 1.02307960 |
| 156 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.02030490 |
| 157 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.01739428 |
| 158 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.01667916 |
| 159 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00883853 |
| 160 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.99928725 |
| 161 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99876385 |
| 162 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.99734346 |
| 163 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.99112207 |
| 164 | JUN_21703547_ChIP-Seq_K562_Human | 0.98218530 |
| 165 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98061202 |
| 166 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.97450648 |
| 167 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.97346463 |
| 168 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97325529 |
| 169 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96790866 |
| 170 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.94474754 |
| 171 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93698673 |
| 172 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.92993223 |
| 173 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.90985604 |
| 174 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.89326575 |
| 175 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88581839 |
| 176 | P68_20966046_ChIP-Seq_HELA_Human | 0.88438857 |
| 177 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.88345734 |
| 178 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87246129 |
| 179 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.86307097 |
| 180 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.86231323 |
| 181 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85966677 |
| 182 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84351717 |
| 183 | ERA_21632823_ChIP-Seq_H3396_Human | 0.83284764 |
| 184 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.82612756 |
| 185 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.82296193 |
| 186 | MYB_26560356_Chip-Seq_TH1_Human | 0.82239134 |
| 187 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.82173700 |
| 188 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82099237 |
| 189 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.81850052 |
| 190 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81607124 |
| 191 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81241405 |
| 192 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.79969993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 5.56004445 |
| 2 | MP0003880_abnormal_central_pattern | 4.47735961 |
| 3 | MP0001188_hyperpigmentation | 3.99183213 |
| 4 | MP0006292_abnormal_olfactory_placode | 3.08344387 |
| 5 | MP0001986_abnormal_taste_sensitivity | 3.07330095 |
| 6 | MP0005409_darkened_coat_color | 2.89336023 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.87924694 |
| 8 | MP0003303_peritoneal_inflammation | 2.77297972 |
| 9 | MP0003136_yellow_coat_color | 2.71577269 |
| 10 | MP0008004_abnormal_stomach_pH | 2.67846296 |
| 11 | MP0003436_decreased_susceptibility_to | 2.66185373 |
| 12 | MP0009379_abnormal_foot_pigmentation | 2.59493345 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.53573785 |
| 14 | MP0009745_abnormal_behavioral_response | 2.51681223 |
| 15 | MP0006276_abnormal_autonomic_nervous | 2.46493573 |
| 16 | MP0009046_muscle_twitch | 2.44328621 |
| 17 | MP0000465_gastrointestinal_hemorrhage | 2.40325405 |
| 18 | MP0001968_abnormal_touch/_nociception | 2.39785267 |
| 19 | MP0003635_abnormal_synaptic_transmissio | 2.33261526 |
| 20 | MP0002272_abnormal_nervous_system | 2.24918312 |
| 21 | MP0001486_abnormal_startle_reflex | 2.20859279 |
| 22 | MP0002064_seizures | 2.18559249 |
| 23 | MP0001800_abnormal_humoral_immune | 2.13640010 |
| 24 | MP0002735_abnormal_chemical_nociception | 2.13275866 |
| 25 | MP0005000_abnormal_immune_tolerance | 2.11676340 |
| 26 | MP0002653_abnormal_ependyma_morphology | 2.10241362 |
| 27 | MP0002876_abnormal_thyroid_physiology | 2.08735544 |
| 28 | MP0004859_abnormal_synaptic_plasticity | 2.08169536 |
| 29 | MP0002572_abnormal_emotion/affect_behav | 2.08102370 |
| 30 | MP0004142_abnormal_muscle_tone | 2.06541917 |
| 31 | MP0001529_abnormal_vocalization | 2.05845942 |
| 32 | MP0002419_abnormal_innate_immunity | 2.05348711 |
| 33 | MP0002723_abnormal_immune_serum | 1.99361462 |
| 34 | MP0002736_abnormal_nociception_after | 1.97635919 |
| 35 | MP0005025_abnormal_response_to | 1.94580045 |
| 36 | MP0001905_abnormal_dopamine_level | 1.93897738 |
| 37 | MP0003787_abnormal_imprinting | 1.91012831 |
| 38 | MP0005645_abnormal_hypothalamus_physiol | 1.90405146 |
| 39 | MP0005387_immune_system_phenotype | 1.90331139 |
| 40 | MP0001790_abnormal_immune_system | 1.90331139 |
| 41 | MP0000685_abnormal_immune_system | 1.89450721 |
| 42 | MP0005646_abnormal_pituitary_gland | 1.89444665 |
| 43 | MP0009764_decreased_sensitivity_to | 1.89113925 |
| 44 | MP0001984_abnormal_olfaction | 1.88720121 |
| 45 | MP0002452_abnormal_antigen_presenting | 1.83339632 |
| 46 | MP0002102_abnormal_ear_morphology | 1.82870733 |
| 47 | MP0001501_abnormal_sleep_pattern | 1.82768072 |
| 48 | MP0002420_abnormal_adaptive_immunity | 1.80736765 |
| 49 | MP0002063_abnormal_learning/memory/cond | 1.79650964 |
| 50 | MP0004381_abnormal_hair_follicle | 1.79391304 |
| 51 | MP0005174_abnormal_tail_pigmentation | 1.79018092 |
| 52 | MP0001819_abnormal_immune_cell | 1.77401540 |
| 53 | MP0005083_abnormal_biliary_tract | 1.74260167 |
| 54 | MP0000015_abnormal_ear_pigmentation | 1.70706766 |
| 55 | MP0002734_abnormal_mechanical_nocicepti | 1.68533305 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.67369355 |
| 57 | MP0001545_abnormal_hematopoietic_system | 1.67369355 |
| 58 | MP0002067_abnormal_sensory_capabilities | 1.67036491 |
| 59 | MP0001970_abnormal_pain_threshold | 1.61459592 |
| 60 | MP0005171_absent_coat_pigmentation | 1.59688732 |
| 61 | MP0002557_abnormal_social/conspecific_i | 1.59050234 |
| 62 | MP0009278_abnormal_bone_marrow | 1.58931057 |
| 63 | MP0001533_abnormal_skeleton_physiology | 1.57402059 |
| 64 | MP0005551_abnormal_eye_electrophysiolog | 1.57145818 |
| 65 | MP0010155_abnormal_intestine_physiology | 1.55350818 |
| 66 | MP0002822_catalepsy | 1.53204624 |
| 67 | MP0000230_abnormal_systemic_arterial | 1.52201669 |
| 68 | MP0004130_abnormal_muscle_cell | 1.51106764 |
| 69 | MP0002398_abnormal_bone_marrow | 1.48026071 |
| 70 | MP0003122_maternal_imprinting | 1.45092472 |
| 71 | MP0004742_abnormal_vestibular_system | 1.43224318 |
| 72 | MP0005379_endocrine/exocrine_gland_phen | 1.42815962 |
| 73 | MP0002638_abnormal_pupillary_reflex | 1.40871233 |
| 74 | MP0000343_altered_response_to | 1.39333933 |
| 75 | MP0003866_abnormal_defecation | 1.38171521 |
| 76 | MP0001663_abnormal_digestive_system | 1.38116898 |
| 77 | MP0003724_increased_susceptibility_to | 1.37407691 |
| 78 | MP0005167_abnormal_blood-brain_barrier | 1.37311488 |
| 79 | MP0001440_abnormal_grooming_behavior | 1.36549317 |
| 80 | MP0000716_abnormal_immune_system | 1.35779173 |
| 81 | MP0002733_abnormal_thermal_nociception | 1.34684952 |
| 82 | MP0001845_abnormal_inflammatory_respons | 1.32050187 |
| 83 | MP0000689_abnormal_spleen_morphology | 1.31718682 |
| 84 | MP0003011_delayed_dark_adaptation | 1.31343696 |
| 85 | MP0004270_analgesia | 1.30620685 |
| 86 | MP0008260_abnormal_autophagy | 1.29314006 |
| 87 | MP0000566_synostosis | 1.29266507 |
| 88 | MP0002405_respiratory_system_inflammati | 1.28071845 |
| 89 | MP0003638_abnormal_response/metabolism_ | 1.26781120 |
| 90 | MP0003828_pulmonary_edema | 1.26450439 |
| 91 | MP0002184_abnormal_innervation | 1.25730860 |
| 92 | MP0006082_CNS_inflammation | 1.22374710 |
| 93 | MP0003879_abnormal_hair_cell | 1.21832468 |
| 94 | MP0001502_abnormal_circadian_rhythm | 1.21391579 |
| 95 | MP0000372_irregular_coat_pigmentation | 1.20868853 |
| 96 | MP0000026_abnormal_inner_ear | 1.20299164 |
| 97 | MP0001963_abnormal_hearing_physiology | 1.19281956 |
| 98 | MP0004510_myositis | 1.18681908 |
| 99 | MP0002429_abnormal_blood_cell | 1.17942464 |
| 100 | MP0002163_abnormal_gland_morphology | 1.17202666 |
| 101 | MP0006072_abnormal_retinal_apoptosis | 1.15384613 |
| 102 | MP0003172_abnormal_lysosome_physiology | 1.14677572 |
| 103 | MP0000631_abnormal_neuroendocrine_gland | 1.13749053 |
| 104 | MP0005377_hearing/vestibular/ear_phenot | 1.13636781 |
| 105 | MP0003878_abnormal_ear_physiology | 1.13636781 |
| 106 | MP0003938_abnormal_ear_development | 1.13143904 |
| 107 | MP0002722_abnormal_immune_system | 1.11775651 |
| 108 | MP0008995_early_reproductive_senescence | 1.11057126 |
| 109 | MP0002277_abnormal_respiratory_mucosa | 1.08078490 |
| 110 | MP0005075_abnormal_melanosome_morpholog | 1.07208720 |
| 111 | MP0008569_lethality_at_weaning | 1.05737019 |
| 112 | MP0001485_abnormal_pinna_reflex | 1.05411594 |
| 113 | MP0004947_skin_inflammation | 1.05318840 |
| 114 | MP0002095_abnormal_skin_pigmentation | 1.03091483 |
| 115 | MP0004924_abnormal_behavior | 1.02813447 |
| 116 | MP0005386_behavior/neurological_phenoty | 1.02813447 |
| 117 | MP0005253_abnormal_eye_physiology | 1.00223176 |
| 118 | MP0002138_abnormal_hepatobiliary_system | 1.00086959 |
| 119 | MP0001851_eye_inflammation | 0.98523346 |
| 120 | MP0008469_abnormal_protein_level | 0.98093452 |
| 121 | MP0009765_abnormal_xenobiotic_induced | 0.98065258 |
| 122 | MP0000778_abnormal_nervous_system | 0.96492725 |
| 123 | MP0010386_abnormal_urinary_bladder | 0.95568917 |
| 124 | MP0002882_abnormal_neuron_morphology | 0.95218294 |
| 125 | MP0005058_abnormal_lysosome_morphology | 0.94955919 |
| 126 | MP0002752_abnormal_somatic_nervous | 0.94510467 |
| 127 | MP0005535_abnormal_body_temperature | 0.94367337 |
| 128 | MP0002751_abnormal_autonomic_nervous | 0.92795786 |
| 129 | MP0008877_abnormal_DNA_methylation | 0.91825750 |
| 130 | MP0000681_abnormal_thyroid_gland | 0.91371401 |
| 131 | MP0003300_gastrointestinal_ulcer | 0.90134404 |
| 132 | MP0003075_altered_response_to | 0.89150912 |
| 133 | MP0005394_taste/olfaction_phenotype | 0.87837569 |
| 134 | MP0005499_abnormal_olfactory_system | 0.87837569 |
| 135 | MP0000049_abnormal_middle_ear | 0.87700650 |
| 136 | MP0009333_abnormal_splenocyte_physiolog | 0.87416530 |
| 137 | MP0009763_increased_sensitivity_to | 0.85849556 |
| 138 | MP0002066_abnormal_motor_capabilities/c | 0.85334774 |
| 139 | MP0002229_neurodegeneration | 0.84656640 |
| 140 | MP0008789_abnormal_olfactory_epithelium | 0.80842568 |
| 141 | MP0001664_abnormal_digestion | 0.80349698 |
| 142 | MP0008875_abnormal_xenobiotic_pharmacok | 0.76236350 |
| 143 | MP0000249_abnormal_blood_vessel | 0.76032664 |
| 144 | MP0002148_abnormal_hypersensitivity_rea | 0.74860112 |
| 145 | MP0005310_abnormal_salivary_gland | 0.74653797 |
| 146 | MP0008874_decreased_physiological_sensi | 0.74300988 |
| 147 | MP0000955_abnormal_spinal_cord | 0.73980424 |
| 148 | MP0009642_abnormal_blood_homeostasis | 0.73754852 |
| 149 | MP0005381_digestive/alimentary_phenotyp | 0.71897205 |
| 150 | MP0004883_abnormal_blood_vessel | 0.71444647 |
| 151 | MP0002928_abnormal_bile_duct | 0.70879981 |
| 152 | MP0000703_abnormal_thymus_morphology | 0.69239497 |
| 153 | MP0002177_abnormal_outer_ear | 0.69043264 |
| 154 | MP0004885_abnormal_endolymph | 0.69022373 |
| 155 | MP0001765_abnormal_ion_homeostasis | 0.68857392 |
| 156 | MP0004145_abnormal_muscle_electrophysio | 0.68425280 |
| 157 | MP0005671_abnormal_response_to | 0.67609275 |
| 158 | MP0003806_abnormal_nucleotide_metabolis | 0.67121033 |
| 159 | MP0003763_abnormal_thymus_physiology | 0.66508195 |
| 160 | MP0002693_abnormal_pancreas_physiology | 0.66454195 |
| 161 | MP0000920_abnormal_myelination | 0.65729715 |
| 162 | MP0005084_abnormal_gallbladder_morpholo | 0.63588454 |
| 163 | MP0002938_white_spotting | 0.62596382 |
| 164 | MP0003183_abnormal_peptide_metabolism | 0.62417539 |
| 165 | MP0008872_abnormal_physiological_respon | 0.59412530 |
| 166 | MP0005410_abnormal_fertilization | 0.58359710 |
| 167 | MP0002160_abnormal_reproductive_system | 0.58319833 |
| 168 | MP0003121_genomic_imprinting | 0.58255648 |
| 169 | MP0009785_altered_susceptibility_to | 0.57991376 |
| 170 | MP0002132_abnormal_respiratory_system | 0.56472413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 7.88962005 |
| 2 | Petechiae (HP:0000967) | 6.28150638 |
| 3 | Menorrhagia (HP:0000132) | 5.76148713 |
| 4 | Purpura (HP:0000979) | 5.72429351 |
| 5 | Abnormal platelet volume (HP:0011876) | 5.44667822 |
| 6 | Epistaxis (HP:0000421) | 5.38769039 |
| 7 | Increased mean platelet volume (HP:0011877) | 5.27931486 |
| 8 | Stomatitis (HP:0010280) | 4.69045696 |
| 9 | Gingival bleeding (HP:0000225) | 4.52171708 |
| 10 | Focal motor seizures (HP:0011153) | 4.38339029 |
| 11 | Spontaneous hematomas (HP:0007420) | 3.75518709 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.74900650 |
| 13 | Hypothermia (HP:0002045) | 3.51579235 |
| 14 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.51112119 |
| 15 | Abnormality of macrophages (HP:0004311) | 3.46719902 |
| 16 | Febrile seizures (HP:0002373) | 3.46621648 |
| 17 | Absent/shortened dynein arms (HP:0200106) | 3.44142994 |
| 18 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.44142994 |
| 19 | Acute necrotizing encephalopathy (HP:0006965) | 3.43406352 |
| 20 | Abnormal ciliary motility (HP:0012262) | 3.39615151 |
| 21 | Myositis (HP:0100614) | 3.38548083 |
| 22 | Mitochondrial inheritance (HP:0001427) | 3.34740256 |
| 23 | Recurrent abscess formation (HP:0002722) | 3.26469686 |
| 24 | Hyperlipoproteinemia (HP:0010980) | 3.26393157 |
| 25 | Recurrent bacterial skin infections (HP:0005406) | 3.22163567 |
| 26 | Eczematoid dermatitis (HP:0000976) | 3.21198596 |
| 27 | Type I transferrin isoform profile (HP:0003642) | 3.18416400 |
| 28 | Encephalitis (HP:0002383) | 3.06955900 |
| 29 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.06417207 |
| 30 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.06417207 |
| 31 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.05001863 |
| 32 | Abnormal platelet function (HP:0011869) | 3.02920411 |
| 33 | Impaired platelet aggregation (HP:0003540) | 3.02920411 |
| 34 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.00873810 |
| 35 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.99596705 |
| 36 | Retrobulbar optic neuritis (HP:0100654) | 2.98840519 |
| 37 | Optic neuritis (HP:0100653) | 2.98840519 |
| 38 | Optic disc pallor (HP:0000543) | 2.98722124 |
| 39 | Orchitis (HP:0100796) | 2.94012445 |
| 40 | Abnormal hair whorl (HP:0010721) | 2.93946006 |
| 41 | Progressive macrocephaly (HP:0004481) | 2.92767868 |
| 42 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.91906737 |
| 43 | Hepatocellular necrosis (HP:0001404) | 2.85908813 |
| 44 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.81261274 |
| 45 | Decreased central vision (HP:0007663) | 2.79824829 |
| 46 | Attenuation of retinal blood vessels (HP:0007843) | 2.78800864 |
| 47 | Medial flaring of the eyebrow (HP:0010747) | 2.74713105 |
| 48 | Episodic fever (HP:0001954) | 2.74383673 |
| 49 | Renal Fanconi syndrome (HP:0001994) | 2.72524143 |
| 50 | Increased hepatocellular lipid droplets (HP:0006565) | 2.71840354 |
| 51 | Increased IgM level (HP:0003496) | 2.70790303 |
| 52 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.68042603 |
| 53 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.65128081 |
| 54 | Increased CSF lactate (HP:0002490) | 2.65018689 |
| 55 | Reduced antithrombin III activity (HP:0001976) | 2.63696986 |
| 56 | 3-Methylglutaconic aciduria (HP:0003535) | 2.63286391 |
| 57 | Myokymia (HP:0002411) | 2.62259296 |
| 58 | Atonic seizures (HP:0010819) | 2.61408045 |
| 59 | Epileptic encephalopathy (HP:0200134) | 2.59531331 |
| 60 | Broad-based gait (HP:0002136) | 2.59294098 |
| 61 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.57169718 |
| 62 | Recurrent fungal infections (HP:0002841) | 2.55939257 |
| 63 | Thyroid-stimulating hormone excess (HP:0002925) | 2.54507648 |
| 64 | Gait imbalance (HP:0002141) | 2.54073852 |
| 65 | Congenital primary aphakia (HP:0007707) | 2.45260363 |
| 66 | True hermaphroditism (HP:0010459) | 2.44664304 |
| 67 | Congenital stationary night blindness (HP:0007642) | 2.44323433 |
| 68 | Abnormality of secondary sexual hair (HP:0009888) | 2.44136725 |
| 69 | Abnormality of the axillary hair (HP:0100134) | 2.44136725 |
| 70 | Poikilocytosis (HP:0004447) | 2.43777227 |
| 71 | Abnormality of lateral ventricle (HP:0030047) | 2.43188501 |
| 72 | Panhypogammaglobulinemia (HP:0003139) | 2.43089941 |
| 73 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.42534475 |
| 74 | Parakeratosis (HP:0001036) | 2.42114874 |
| 75 | Hypochromic microcytic anemia (HP:0004840) | 2.41990516 |
| 76 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.41261345 |
| 77 | Abnormality of iron homeostasis (HP:0011031) | 2.39670059 |
| 78 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.39620783 |
| 79 | Acute encephalopathy (HP:0006846) | 2.38941314 |
| 80 | Nephrogenic diabetes insipidus (HP:0009806) | 2.38680633 |
| 81 | Progressive cerebellar ataxia (HP:0002073) | 2.38121344 |
| 82 | Pancreatic cysts (HP:0001737) | 2.37237495 |
| 83 | Meningitis (HP:0001287) | 2.37071182 |
| 84 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.36868894 |
| 85 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.35735314 |
| 86 | Hypochromic anemia (HP:0001931) | 2.31293792 |
| 87 | Tubulointerstitial nephritis (HP:0001970) | 2.28493920 |
| 88 | Bruising susceptibility (HP:0000978) | 2.26267391 |
| 89 | Mediastinal lymphadenopathy (HP:0100721) | 2.25920310 |
| 90 | Nonprogressive disorder (HP:0003680) | 2.24568110 |
| 91 | Chest pain (HP:0100749) | 2.22640223 |
| 92 | Gastrointestinal infarctions (HP:0005244) | 2.22498980 |
| 93 | Increased cerebral lipofuscin (HP:0011813) | 2.22190167 |
| 94 | Median cleft lip (HP:0000161) | 2.21480641 |
| 95 | Severe visual impairment (HP:0001141) | 2.19590780 |
| 96 | Increased serum ferritin (HP:0003281) | 2.19103644 |
| 97 | Focal seizures (HP:0007359) | 2.18973178 |
| 98 | Acanthocytosis (HP:0001927) | 2.17008511 |
| 99 | Recurrent skin infections (HP:0001581) | 2.16511616 |
| 100 | Leukocytosis (HP:0001974) | 2.16510472 |
| 101 | Chromsome breakage (HP:0040012) | 2.16375788 |
| 102 | Arterial thrombosis (HP:0004420) | 2.15073180 |
| 103 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.14732838 |
| 104 | White forelock (HP:0002211) | 2.13782828 |
| 105 | Limb dystonia (HP:0002451) | 2.13505708 |
| 106 | Hepatosplenomegaly (HP:0001433) | 2.13227292 |
| 107 | Patchy hypopigmentation of hair (HP:0011365) | 2.12988747 |
| 108 | Microvesicular hepatic steatosis (HP:0001414) | 2.12171195 |
| 109 | Recurrent cutaneous fungal infections (HP:0011370) | 2.11918338 |
| 110 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.11918338 |
| 111 | Increased IgE level (HP:0003212) | 2.11232124 |
| 112 | Keratoconjunctivitis sicca (HP:0001097) | 2.09088199 |
| 113 | Polyphagia (HP:0002591) | 2.08748145 |
| 114 | Vasculitis (HP:0002633) | 2.07935224 |
| 115 | Keratoconjunctivitis (HP:0001096) | 2.06669021 |
| 116 | Abnormality of the renal cortex (HP:0011035) | 2.06430819 |
| 117 | Pancreatic fibrosis (HP:0100732) | 2.05643610 |
| 118 | Abolished electroretinogram (ERG) (HP:0000550) | 2.05405916 |
| 119 | Urticaria (HP:0001025) | 2.04666275 |
| 120 | Polydipsia (HP:0001959) | 2.02314869 |
| 121 | Abnormal drinking behavior (HP:0030082) | 2.02314869 |
| 122 | Abnormality of the prostate (HP:0008775) | 2.01678530 |
| 123 | Abnormality of midbrain morphology (HP:0002418) | 2.00692157 |
| 124 | Molar tooth sign on MRI (HP:0002419) | 2.00692157 |
| 125 | Abnormality of renal resorption (HP:0011038) | 1.99946067 |
| 126 | Fair hair (HP:0002286) | 1.98609715 |
| 127 | Conjunctival telangiectasia (HP:0000524) | 1.97580675 |
| 128 | Pulmonary embolism (HP:0002204) | 1.97428042 |
| 129 | Septo-optic dysplasia (HP:0100842) | 1.97064159 |
| 130 | Dyschromatopsia (HP:0007641) | 1.96913102 |
| 131 | Generalized hypopigmentation of hair (HP:0011358) | 1.96615743 |
| 132 | Microcytic anemia (HP:0001935) | 1.95826578 |
| 133 | Abnormal pupillary function (HP:0007686) | 1.95627993 |
| 134 | Lipid accumulation in hepatocytes (HP:0006561) | 1.94873361 |
| 135 | Autoimmune hemolytic anemia (HP:0001890) | 1.94806964 |
| 136 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.92578067 |
| 137 | Diplopia (HP:0000651) | 1.91823732 |
| 138 | Abnormality of binocular vision (HP:0011514) | 1.91823732 |
| 139 | Gaze-evoked nystagmus (HP:0000640) | 1.91731237 |
| 140 | Optic nerve hypoplasia (HP:0000609) | 1.91437502 |
| 141 | Esotropia (HP:0000565) | 1.90795061 |
| 142 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.90432748 |
| 143 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.90432748 |
| 144 | Abnormal protein glycosylation (HP:0012346) | 1.90432748 |
| 145 | Abnormal glycosylation (HP:0012345) | 1.90432748 |
| 146 | Rhinitis (HP:0012384) | 1.89893977 |
| 147 | Abnormality of the renal medulla (HP:0100957) | 1.89657906 |
| 148 | Hepatic necrosis (HP:0002605) | 1.89428713 |
| 149 | Aplasia cutis congenita (HP:0001057) | 1.89304175 |
| 150 | Progressive inability to walk (HP:0002505) | 1.88645156 |
| 151 | Inflammation of the large intestine (HP:0002037) | 1.87669046 |
| 152 | Vertigo (HP:0002321) | 1.86495869 |
| 153 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.85724564 |
| 154 | Dry hair (HP:0011359) | 1.85643924 |
| 155 | Hemoptysis (HP:0002105) | 1.85605178 |
| 156 | Chronic otitis media (HP:0000389) | 1.84419248 |
| 157 | Exercise intolerance (HP:0003546) | 1.84023502 |
| 158 | Split foot (HP:0001839) | 1.83777229 |
| 159 | Hyperthyroidism (HP:0000836) | 1.82364402 |
| 160 | Agitation (HP:0000713) | 1.82224986 |
| 161 | Genital tract atresia (HP:0001827) | 1.82139443 |
| 162 | Vaginal atresia (HP:0000148) | 1.81337119 |
| 163 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.81037583 |
| 164 | Nasolacrimal duct obstruction (HP:0000579) | 1.80119259 |
| 165 | Nephronophthisis (HP:0000090) | 1.79746426 |
| 166 | Hyperventilation (HP:0002883) | 1.79525832 |
| 167 | Abnormal sex determination (HP:0012244) | 1.78283176 |
| 168 | Sex reversal (HP:0012245) | 1.78283176 |
| 169 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.78241995 |
| 170 | Exertional dyspnea (HP:0002875) | 1.77901105 |
| 171 | Duplicated collecting system (HP:0000081) | 1.76895484 |
| 172 | Male pseudohermaphroditism (HP:0000037) | 1.75940303 |
| 173 | Poor suck (HP:0002033) | 1.75189074 |
| 174 | Generalized tonic-clonic seizures (HP:0002069) | 1.74243343 |
| 175 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.74214934 |
| 176 | Short tibia (HP:0005736) | 1.73204369 |
| 177 | Congenital sensorineural hearing impairment (HP:0008527) | 1.72387096 |
| 178 | Absent septum pellucidum (HP:0001331) | 1.71116694 |
| 179 | Dialeptic seizures (HP:0011146) | 1.70949410 |
| 180 | Obstructive lung disease (HP:0006536) | 1.70809643 |
| 181 | Chronic obstructive pulmonary disease (HP:0006510) | 1.70809643 |
| 182 | Absence seizures (HP:0002121) | 1.70675432 |
| 183 | Abnormality of the renal collecting system (HP:0004742) | 1.69617369 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 5.38184212 |
| 2 | TNIK | 4.50055615 |
| 3 | TAOK3 | 3.37951115 |
| 4 | MAP2K7 | 2.98309453 |
| 5 | MUSK | 2.97696082 |
| 6 | BTK | 2.83962381 |
| 7 | MKNK2 | 2.80184753 |
| 8 | MAP3K12 | 2.70167579 |
| 9 | STK16 | 2.56879982 |
| 10 | MAP4K1 | 2.49397572 |
| 11 | NTRK3 | 2.26173928 |
| 12 | GRK6 | 2.24288099 |
| 13 | FRK | 2.18196123 |
| 14 | PTK2B | 2.07696701 |
| 15 | ADRBK2 | 1.98398291 |
| 16 | ZAP70 | 1.93312544 |
| 17 | SRPK1 | 1.90469629 |
| 18 | MAP2K3 | 1.87668167 |
| 19 | CDK19 | 1.86367890 |
| 20 | PRPF4B | 1.82955163 |
| 21 | FES | 1.81314929 |
| 22 | MAP4K2 | 1.79957200 |
| 23 | CSF1R | 1.77534402 |
| 24 | IRAK3 | 1.74563070 |
| 25 | MAP3K11 | 1.72260789 |
| 26 | IRAK4 | 1.72120087 |
| 27 | BMX | 1.69859912 |
| 28 | MAPK13 | 1.66758024 |
| 29 | DAPK2 | 1.65196836 |
| 30 | MKNK1 | 1.63836269 |
| 31 | HCK | 1.61883661 |
| 32 | ITK | 1.58973940 |
| 33 | TLK1 | 1.55321498 |
| 34 | EPHA4 | 1.49928335 |
| 35 | CSK | 1.48731576 |
| 36 | IKBKB | 1.46171570 |
| 37 | GRK7 | 1.41827648 |
| 38 | EIF2AK3 | 1.40134238 |
| 39 | TXK | 1.35967756 |
| 40 | IRAK2 | 1.32621585 |
| 41 | TNK2 | 1.30077252 |
| 42 | BLK | 1.29191217 |
| 43 | BMPR2 | 1.27585709 |
| 44 | NEK6 | 1.22688403 |
| 45 | IRAK1 | 1.16900628 |
| 46 | YES1 | 1.16246444 |
| 47 | OXSR1 | 1.14057339 |
| 48 | JAK3 | 1.13338505 |
| 49 | BCKDK | 1.12362429 |
| 50 | LCK | 1.11463319 |
| 51 | BMPR1B | 1.11357165 |
| 52 | NLK | 1.10271684 |
| 53 | MAP3K4 | 1.10141448 |
| 54 | RIPK4 | 1.09544278 |
| 55 | EIF2AK2 | 1.08503501 |
| 56 | GRK5 | 1.07258499 |
| 57 | MATK | 1.07246526 |
| 58 | MAPKAPK3 | 1.05748451 |
| 59 | ACVR1B | 1.03488999 |
| 60 | MAPKAPK5 | 1.02901270 |
| 61 | TAOK1 | 1.00044820 |
| 62 | PIK3CG | 0.97760166 |
| 63 | NME1 | 0.97718524 |
| 64 | MARK1 | 0.95053755 |
| 65 | PLK2 | 0.93627269 |
| 66 | CAMKK2 | 0.93263959 |
| 67 | GRK1 | 0.93203945 |
| 68 | STK39 | 0.93123243 |
| 69 | PIM2 | 0.92543139 |
| 70 | CDK3 | 0.92021503 |
| 71 | TEC | 0.88358281 |
| 72 | VRK1 | 0.87589393 |
| 73 | PRKCQ | 0.87126615 |
| 74 | MARK3 | 0.85979915 |
| 75 | NTRK2 | 0.85944975 |
| 76 | JAK2 | 0.85252671 |
| 77 | NUAK1 | 0.85202588 |
| 78 | AKT3 | 0.85132684 |
| 79 | EPHB1 | 0.84696410 |
| 80 | CAMK2A | 0.83423819 |
| 81 | TYK2 | 0.82893171 |
| 82 | CAMK1 | 0.81302134 |
| 83 | PDK1 | 0.80840555 |
| 84 | PRKCG | 0.79360695 |
| 85 | CAMK2B | 0.78792467 |
| 86 | MAPK12 | 0.74664090 |
| 87 | UHMK1 | 0.74092752 |
| 88 | TBK1 | 0.72841043 |
| 89 | PKN1 | 0.71618485 |
| 90 | EPHA3 | 0.70745600 |
| 91 | MAP2K6 | 0.68570310 |
| 92 | ARAF | 0.67406186 |
| 93 | MAP3K7 | 0.66888189 |
| 94 | ZAK | 0.66564175 |
| 95 | BRAF | 0.65406565 |
| 96 | MARK2 | 0.65328567 |
| 97 | MST4 | 0.65273045 |
| 98 | ADRBK1 | 0.65173239 |
| 99 | NME2 | 0.65134746 |
| 100 | MAP3K14 | 0.64796328 |
| 101 | PINK1 | 0.64732743 |
| 102 | MAPK15 | 0.64226675 |
| 103 | TESK2 | 0.63737768 |
| 104 | PRKCE | 0.62470111 |
| 105 | DYRK1A | 0.61979951 |
| 106 | MAP3K13 | 0.59940390 |
| 107 | MAP3K3 | 0.59889675 |
| 108 | PNCK | 0.58552077 |
| 109 | MAP3K5 | 0.58404092 |
| 110 | CCNB1 | 0.55858259 |
| 111 | MYLK | 0.55499078 |
| 112 | PDPK1 | 0.54830441 |
| 113 | CAMK2D | 0.54738228 |
| 114 | CDK5 | 0.54367257 |
| 115 | SIK3 | 0.54077500 |
| 116 | RPS6KA6 | 0.53937236 |
| 117 | DYRK1B | 0.52377838 |
| 118 | MAP3K1 | 0.52322289 |
| 119 | MINK1 | 0.50190777 |
| 120 | FYN | 0.50166345 |
| 121 | PBK | 0.50049268 |
| 122 | INSRR | 0.49863196 |
| 123 | CDK8 | 0.49350011 |
| 124 | CLK1 | 0.48731687 |
| 125 | WNK4 | 0.48182975 |
| 126 | PRKD1 | 0.47002525 |
| 127 | DAPK1 | 0.46591742 |
| 128 | LYN | 0.46331191 |
| 129 | KDR | 0.45126635 |
| 130 | TIE1 | 0.44382356 |
| 131 | PAK1 | 0.44359983 |
| 132 | PRKACA | 0.43865605 |
| 133 | HIPK2 | 0.43490327 |
| 134 | PRKD2 | 0.43398836 |
| 135 | SYK | 0.43381950 |
| 136 | STK3 | 0.41182459 |
| 137 | STK11 | 0.39253968 |
| 138 | STK38 | 0.38508115 |
| 139 | DAPK3 | 0.38262202 |
| 140 | MAP2K4 | 0.38118194 |
| 141 | SIK2 | 0.37332097 |
| 142 | DYRK3 | 0.37064898 |
| 143 | FGR | 0.36938701 |
| 144 | PRKG1 | 0.36927675 |
| 145 | TAOK2 | 0.36735612 |
| 146 | PRKCD | 0.35786754 |
| 147 | PIM1 | 0.35591283 |
| 148 | RPS6KL1 | 0.34991978 |
| 149 | RPS6KC1 | 0.34991978 |
| 150 | CAMK2G | 0.34795353 |
| 151 | KIT | 0.34416097 |
| 152 | IKBKE | 0.33741443 |
| 153 | CSNK1G1 | 0.32957559 |
| 154 | SGK223 | 0.29950915 |
| 155 | SGK494 | 0.29950915 |
| 156 | DYRK2 | 0.29687768 |
| 157 | MAPK4 | 0.28894738 |
| 158 | BCR | 0.28007788 |
| 159 | PRKCA | 0.27180909 |
| 160 | CSNK1G3 | 0.26757699 |
| 161 | CSNK1A1 | 0.26031088 |
| 162 | SGK1 | 0.25955358 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.77909800 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.33525508 |
| 3 | Platelet activation_Homo sapiens_hsa04611 | 3.07787081 |
| 4 | Phototransduction_Homo sapiens_hsa04744 | 2.98415002 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 2.45822865 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.30349729 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.29762658 |
| 8 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.27886013 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.25063750 |
| 10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.19820889 |
| 11 | Taste transduction_Homo sapiens_hsa04742 | 2.19286176 |
| 12 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.17540028 |
| 13 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.09238170 |
| 14 | Alzheimers disease_Homo sapiens_hsa05010 | 2.06180043 |
| 15 | Olfactory transduction_Homo sapiens_hsa04740 | 2.04510275 |
| 16 | GABAergic synapse_Homo sapiens_hsa04727 | 2.03611218 |
| 17 | Protein export_Homo sapiens_hsa03060 | 1.97589799 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.91243101 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.88007061 |
| 20 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.82341231 |
| 21 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.80397217 |
| 22 | Huntingtons disease_Homo sapiens_hsa05016 | 1.79972965 |
| 23 | Ribosome_Homo sapiens_hsa03010 | 1.74674512 |
| 24 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.71305185 |
| 25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.60906365 |
| 26 | Circadian entrainment_Homo sapiens_hsa04713 | 1.56817240 |
| 27 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.50106646 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.45562081 |
| 29 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.44562273 |
| 30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.38046681 |
| 31 | Long-term depression_Homo sapiens_hsa04730 | 1.35869694 |
| 32 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.35182819 |
| 33 | Tuberculosis_Homo sapiens_hsa05152 | 1.33593412 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.33240332 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.32373668 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.30613955 |
| 37 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.29556667 |
| 38 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.25988574 |
| 39 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.22929649 |
| 40 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.22648690 |
| 41 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.22031555 |
| 42 | Salivary secretion_Homo sapiens_hsa04970 | 1.21683295 |
| 43 | Homologous recombination_Homo sapiens_hsa03440 | 1.20433722 |
| 44 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.17346125 |
| 45 | RNA polymerase_Homo sapiens_hsa03020 | 1.12701970 |
| 46 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.11759661 |
| 47 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.11715550 |
| 48 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.11080537 |
| 49 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.10443661 |
| 50 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.10126265 |
| 51 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.05387806 |
| 52 | Cocaine addiction_Homo sapiens_hsa05030 | 1.04453041 |
| 53 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.04156361 |
| 54 | Other glycan degradation_Homo sapiens_hsa00511 | 1.03148310 |
| 55 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.02982360 |
| 56 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.02578316 |
| 57 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.02326544 |
| 58 | Long-term potentiation_Homo sapiens_hsa04720 | 0.99279416 |
| 59 | Basal transcription factors_Homo sapiens_hsa03022 | 0.98681692 |
| 60 | Insulin secretion_Homo sapiens_hsa04911 | 0.97349449 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.96258520 |
| 62 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.95879065 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.95681137 |
| 64 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.94193529 |
| 65 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.90037921 |
| 66 | Purine metabolism_Homo sapiens_hsa00230 | 0.88852505 |
| 67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.88692924 |
| 68 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.88435837 |
| 69 | Proteasome_Homo sapiens_hsa03050 | 0.87583949 |
| 70 | Viral myocarditis_Homo sapiens_hsa05416 | 0.86461050 |
| 71 | Allograft rejection_Homo sapiens_hsa05330 | 0.86406431 |
| 72 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.83353501 |
| 73 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81736704 |
| 74 | Renin secretion_Homo sapiens_hsa04924 | 0.81153358 |
| 75 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.80303646 |
| 76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78089875 |
| 77 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.77712813 |
| 78 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.76285808 |
| 79 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.75366685 |
| 80 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.71511425 |
| 81 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.71176041 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.70526521 |
| 83 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.70435992 |
| 84 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.70080004 |
| 85 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.68500135 |
| 86 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.67955750 |
| 87 | Lysosome_Homo sapiens_hsa04142 | 0.66246390 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.64394379 |
| 89 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.64323688 |
| 90 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.63996834 |
| 91 | Asthma_Homo sapiens_hsa05310 | 0.62516448 |
| 92 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.61437075 |
| 93 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60866160 |
| 94 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.60389030 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60098740 |
| 96 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.59561190 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.58734025 |
| 98 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.58192615 |
| 99 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.57197727 |
| 100 | Measles_Homo sapiens_hsa05162 | 0.57069212 |
| 101 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.56291518 |
| 102 | Phagosome_Homo sapiens_hsa04145 | 0.55384111 |
| 103 | Alcoholism_Homo sapiens_hsa05034 | 0.54983512 |
| 104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53326136 |
| 105 | Shigellosis_Homo sapiens_hsa05131 | 0.50875706 |
| 106 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.50718656 |
| 107 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.50567869 |
| 108 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.50393554 |
| 109 | Melanogenesis_Homo sapiens_hsa04916 | 0.50208521 |
| 110 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.48453084 |
| 111 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.47536015 |
| 112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.47504231 |
| 113 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.47205556 |
| 114 | Influenza A_Homo sapiens_hsa05164 | 0.47184862 |
| 115 | Gap junction_Homo sapiens_hsa04540 | 0.47012072 |
| 116 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.46863713 |
| 117 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.46207502 |
| 118 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.46200704 |
| 119 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.45843925 |
| 120 | Axon guidance_Homo sapiens_hsa04360 | 0.45649481 |
| 121 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.44590758 |
| 122 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.44443938 |
| 123 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44269532 |
| 124 | Legionellosis_Homo sapiens_hsa05134 | 0.43078527 |
| 125 | Spliceosome_Homo sapiens_hsa03040 | 0.42613871 |
| 126 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.42587176 |
| 127 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.42318763 |
| 128 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41372200 |
| 129 | Pertussis_Homo sapiens_hsa05133 | 0.41359547 |
| 130 | ABC transporters_Homo sapiens_hsa02010 | 0.41182595 |
| 131 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.38091561 |
| 132 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.37301442 |
| 133 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.34148313 |
| 134 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.34109375 |
| 135 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.33838108 |
| 136 | Metabolic pathways_Homo sapiens_hsa01100 | 0.32529213 |
| 137 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31801242 |
| 138 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.31072707 |
| 139 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.30370899 |
| 140 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.28308359 |
| 141 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27998654 |
| 142 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.27165184 |
| 143 | Malaria_Homo sapiens_hsa05144 | 0.23905935 |

